Combination of Biological Agents in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Case Series and Review of the Literature.

CONCLUSION: In pediatric IBD, combining biological agents seems to be safe and beneficial in selected patients. The safety should be addressed in long-term follow-up studies.
PMID: 32378002 [PubMed - as supplied by publisher]

Source: Paediatric Drugs - May 6, 2020 Category: Pediatrics Authors: Olbjørn C, Rove JB, Jahnsen J Tags: Paediatr Drugs Source Type: research